Dap10 co-stimulation enhances the anti-HCC efficacy of NKp30 chimeric antigen receptor T cells
Chimeric antigen receptor (CAR) T-cell immunotherapy has made significant breakthroughs in the treatment of relapsed or refractory hematologic malignancies, but its efficacy in solid tumors remains limited. In this study, we developed a chimeric NKp30 (chNKp30) receptor whose ligand, B7H6, is often...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2025-07-01
|
| coleção: | Translational Oncology |
| Assuntos: | |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S1936523325001561 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|